Use this famotidine pediatric dose calculator to convert mg/kg plans into accurate mL dosing for Pepcid oral suspension, including infant reflux plans when a clinician has recommended treatment.
famotidine by weight
Families often search for Pepcid while prescriptions often say famotidine. The calculator should keep both names visible and convert mg/kg dosing into the 40 mg/5 mL liquid when that is the product in hand.
mL per dose = prescribed famotidine mg per dose / (40 mg / 5 mL), which equals prescribed mg per dose / 8 mg per mL.
If the plan is 4 mg famotidine per dose and the bottle is 40 mg/5 mL, the measured volume is 0.5 mL per dose.
Specific dosing support
Practical dosing guide
Use this page to match the famotidine plan to the child's age, daily schedule, and the exact liquid or tablet form in hand. Pepcid is the brand name for famotidine.
Pepcid (famotidine) reduces stomach acid for reflux and ulcer symptoms in infants and children. Use the pediatric dose calculator to estimate weight-based (mg/kg) dosing and match common liquid strengths like 40 mg/5 mL.
Rapid onset (within 1 hour) and 10–12 hour duration make twice-daily dosing sufficient for most reflux and ulcer regimens; refractory symptoms may require bedtime dosing or escalation to PPI therapy.
Dose reduction is necessary in infants and children with renal impairment due to risk of bradycardia, agitation, or CNS toxicity—monitor creatinine and adjust per weight-based recommendations.
Pepcid (Famotidine) helps manage stomach acid and digestive issues in children. It's commonly used to treat conditions that cause discomfort from excess stomach acid, helping children feel better and eat comfortably.
Gastroesophageal Reflux Disease (GERD): Famotidine may be used for symptomatic GERD or suspected acid-related symptoms (e.g., irritability, feeding refusal, or discomfort). It is generally considered in infants or children not responding to non-pharmacologic measures.
Peptic Ulcer Disease (Gastric and Duodenal): Used for treatment and maintenance of healing in duodenal or gastric ulcers in pediatric patients, especially when acid suppression is needed for ulcer resolution.
Esophagitis (Erosive or Non-erosive): Used to reduce acid exposure and support healing of esophageal lining in children with confirmed or suspected erosive esophagitis due to reflux.
Stress Ulcer Prophylaxis (Inpatient Settings): Famotidine may be administered to hospitalized children at risk for stress-related mucosal damage (e.g., mechanical ventilation, sepsis).
Hypersecretory Conditions (e.g., Zollinger-Ellison Syndrome): Used as part of acid suppression therapy in rare pediatric cases with pathologic gastric acid hypersecretion. Famotidine helps control acid levels and reduce complications.
Famotidine (Pepcid) is generally well tolerated in children. Side effects are typically mild, including headache, dizziness, constipation, and diarrhea. Rarely, allergic reactions or cardiac effects may occur. Below are typical side effects and guidance on monitoring: Most side effects are mild and temporary. Keep your child hydrated, use the medicine exactly as prescribed, and call your pediatrician for red-flag symptoms like trouble breathing, severe rash or swelling, persistent vomiting, signs of dehydration, or blood in stool.
Pepcid (famotidine) works through a targeted mechanism that provides effective acid reduction while maintaining some normal stomach function, making it particularly suitable for children. The medication specifically blocks histamine H2 receptors on the acid-producing cells (parietal cells) in the stomach lining. To understand this, imagine the stomach has millions of tiny acid pumps, and these pumps have different 'switches' that turn them on. One of the main switches is histamine, which normally tells the stomach to produce acid when food arrives. Pepcid works by blocking these histamine switches, preventing the signal from reaching the acid pumps. This reduces acid production by about 70-80%, which is enough to relieve symptoms and allow healing while still maintaining some acid for normal digestion. Unlike proton pump inhibitors that completely shut down acid production, Pepcid's more moderate approach preserves some stomach acid, which is important for digesting proteins, absorbing certain nutrients like iron and calcium, and protecting against some infections. The medication begins working within one hour of taking it, reaches peak effect in 1-3 hours, and continues working for 10-12 hours. This relatively long duration of action allows for convenient once or twice-daily dosing. Pepcid is highly selective for H2 receptors in the stomach and has minimal effects on other histamine receptors in the body, which is why it doesn't cause drowsiness like antihistamines that block H1 receptors. The drug undergoes minimal metabolism in the liver and is primarily eliminated unchanged by the kidneys, which explains why it has so few drug interactions compared to older H2 blockers like cimetidine.
Pepcid is used to treat conditions related to excess stomach acid, such as gastroesophageal reflux disease (GERD), peptic ulcers, and esophagitis in children. It works by decreasing the amount of acid the stomach makes, which helps relieve symptoms like pain, vomiting, or feeding issues. It may also be used in hospitals to prevent stress ulcers in critically ill pediatric patients.
Famotidine begins reducing stomach acid within an hour of administration, and full symptom relief may occur over a few days. For reflux, you may see gradual improvement in vomiting or discomfort. Ulcer healing can take several weeks. If your child’s symptoms are not improving after a few days or seem to worsen, follow up with your pediatric provider for reassessment.
If you miss a dose, give it as soon as you remember – unless it's close to the next scheduled dose. In that case, skip the missed dose and continue the regular schedule. Do not double up to make up for a missed dose. If your child spits out or vomits the dose right away, consult the pediatrician or pharmacist – it may be appropriate to repeat depending on timing.
Yes. Famotidine can be given with or without food. Taking it before meals may help optimize acid suppression and reduce symptoms. It’s safe to give with milk or formula. Some caregivers find it helpful to give it before breakfast or dinner if used once or twice daily. Just try to give it at the same time each day for consistency.
Pepcid is generally considered safe for short- to moderate-term use under medical guidance. Long-term use should be periodically reviewed by a provider to ensure it's still needed and to monitor for any potential side effects or nutrient absorption issues. It should not be used indefinitely without follow-up. If your child requires prolonged acid suppression, the underlying diagnosis should be clearly established.
Infant dosing is weight-based and may be once or twice daily depending on age and kidney function. Use the calculator with the mg/kg/day target from your clinician to convert to a safe mL dose.
Yes. Pepcid is the brand name for famotidine. If your prescription is written in mg/kg or total mg, the calculator converts that plan into mL for common liquid strengths such as 40 mg/5 mL.
Once-daily bedtime dosing is often used when reflux symptoms are mostly nighttime or milder, while twice-daily dosing is more common when symptoms are persistent or clearly breaking through during the day. Use the exact schedule chosen by your clinician and let the calculator handle the strength conversion.
Yes, the 40 mg/5 mL suspension is commonly used when infants need precise famotidine dosing by weight. The key is to use the exact mg or mg/kg plan from the clinician and convert that into the correct milliliter dose with an oral syringe.
FDA Approved Labeling for Pepcid (Famotidine)
SourcePediatric Gastroesophageal Reflux Disease (GERD) Treatment Guidelines
SourcePediatric Peptic Ulcer Disease (Gastric and Duodenal) Treatment Guidelines
SourcePediatric Esophagitis (Erosive or Non-erosive) Treatment Guidelines
SourcePediatric Stress Ulcer Prophylaxis (Inpatient Settings) Treatment Guidelines
SourcePediatric Hypersecretory Conditions (e.g., Zollinger-Ellison Syndrome) Treatment Guidelines
Source